Example: bachelor of science
MYDRIACYL Eye Drops - Medsafe
Internal document code Myd110418cNZ PAGE: 1 MYDRIACYL TM Eye Drops Tropicamide Ophthalmic Solution 0.5% & 1.0% CONSUMER MEDICINE INFORMATION
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
PolyTears datasheet 20131027 - Medsafe
www.medsafe.govt.nzNAME AND ADDRESS OF THE SPONSOR Ioquin (A Division of Alcon Laboratories (Australia) Pty Ltd) 25 Frenchs Forest Road East FRENCHS FOREST NSW 2086
Pedestrian Slip Resistance testing to AS/NZS …
www.equus.co.nzCentral Laboratories Report 10-527919.85 Pedestrian Slip Resistance testing to AS/NZS 3661.1: 1993 for Equus. S.M. Potter September 2010 …
Wave Category Donor Item 2016 Item Description ...
wellingtonpta.org2016 Eat, Drink & Bid Merry - Auction Item List Item # Wave Category Donor Item 2016 Item Description Restrictions Fair Market Value 1 Silver Entertainment
Operational Guideline: Design and Construction of …
www.foodsafety.govt.nzTe Pou Oranga Kai O Aotearoa Operational Guideline: Design and Construction of Dairy Premises and Equipment 13 April 2006 New Zealand Food Safety Authority
NATIONAL FORAGE TESTING ASSOCIATION PO …
www.foragetesting.orgPhone: 402-416-0052 Email: nfta@foragetesting.org Fax: 831-303-4938 Website: www.foragetesting.org NATIONAL FORAGE TESTING ASSOCIATION PO Box 1470
IDC
www.idc-online.comIDC TeChnologIes IDC Technologies was founded in 1992. Since then, we have built a strong reputation globally as a provider of practical, technical training.
SECTION 25 BUSINESS DISTRICT COMMERCIAL …
www.london.caSECTION 25 . BUSINESS DISTRICT COMMERCIAL (BDC) ZONE . 25.1 GENERAL PURPOSE OF THE BDC ZONE This Zone is normally intended to implement the Main Street Commercial Corridor